This report shows patients by high and moderate risk as defined by ATAGI and utilised in the national roadmap.


It uses the same categories as the 'General' COVID-19 report:


  • Dose 1 Categories
    • Dose 1 Astrazeneca (Vaxzevria) 
    • Dose 1 Pfizer (Comirnaty)
    • Dose 1 Unknown
  • Dose 2 Categories
    • Dose 2 Astrazeneca (Vaxzevria)
    • Dose 2 Pfizer (Comirnaty)
    • Dose 2 Unknown
  • Declined 
  • Not Recorded

But in this report only patients with underlying risk factors are reported along with their vaccine status.